These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 7221100

  • 1. [Fibrinolysis in diabetes mellitus and its relation to retinopathy].
    Sánchez Martín S, Miralles García JM, Alberca Silva I, De Pablo Dávila F, Meza Mendoza S.
    Rev Clin Esp; 1980 Dec 15; 159(5):355-8. PubMed ID: 7221100
    [No Abstract] [Full Text] [Related]

  • 2. [Platelet aggregation in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM, Pablo Dávila F, Sánchez Martín S, Alberca Silva I.
    Rev Clin Esp; 1980 May 15; 157(3):183-85. PubMed ID: 7403595
    [No Abstract] [Full Text] [Related]

  • 3. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy].
    Sánchez Martín S, García Díez LC, García Marcos MA, Miralles García JM.
    Rev Clin Esp; 1983 May 15; 169(3):189-90. PubMed ID: 6612032
    [No Abstract] [Full Text] [Related]

  • 4. Plasma prekallikrein as a risk factor for diabetic retinopathy.
    Kedzierska K, Ciechanowski K, Gołembiewska E, Safranow K, Ciechanowicz A, Domański L, Myślak M, Róźański J.
    Arch Med Res; 2005 May 15; 36(5):539-43. PubMed ID: 16099335
    [Abstract] [Full Text] [Related]

  • 5. [Behavior of factor VIII in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM, De Pablo Dávila F, Sánchez Martin S, Alberca Silva I.
    Rev Clin Esp; 1980 Feb 15; 156(3):193-6. PubMed ID: 6966066
    [No Abstract] [Full Text] [Related]

  • 6. [Fibrinolytic activity and the course of diabetic retinopathy].
    Fukuda M.
    Ganka; 1970 Dec 15; 12(12):1039-44. PubMed ID: 5530821
    [No Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K.
    Arterioscler Thromb Vasc Biol; 2008 Apr 15; 28(4):786-91. PubMed ID: 18239151
    [Abstract] [Full Text] [Related]

  • 8. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu, Markova OA, Grishin VL, Efimov VS.
    Vestn Oftalmol; 2004 Apr 15; 120(3):29-31. PubMed ID: 15216770
    [Abstract] [Full Text] [Related]

  • 9. [Serotonin in diabetic retinopathy].
    Andrzejewska-Buczko J, Pawlak D, Walkowiak M, Stankiewicz A.
    Klin Oczna; 1996 Feb 15; 98(2):101-4. PubMed ID: 9026563
    [Abstract] [Full Text] [Related]

  • 10. Platelet aggregation in diabetic retinopathy.
    Khosla PK, Mahabaleshwara M, Tewari HK, Saraya AK.
    Indian J Ophthalmol; 1981 Oct 15; 29(3):277-82. PubMed ID: 7346443
    [No Abstract] [Full Text] [Related]

  • 11. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
    Zhaboedov GD, Kopaenko AI.
    Vestn Oftalmol; 2005 Oct 15; 121(6):29-31. PubMed ID: 16405060
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of diabetic retinopathy in relation to duration of diabetes mellitus in community hospitals of Lampang.
    Jenchitr W, Samaiporn S, Lertmeemongkolchai P, Chongwiriyanurak T, Anujaree P, Chayaboon D, Pohikamjorn A.
    J Med Assoc Thai; 2004 Nov 15; 87(11):1321-6. PubMed ID: 15825707
    [Abstract] [Full Text] [Related]

  • 13. Reduced forearm reactive hyperaemia in normoalbuminuric subjects with Type 1 diabetes and retinopathy.
    Gibney J, Turner B, Weis U, Meeking DR, Cansfield J, Watts GF, Shaw KM, Cummings MH.
    Diabet Med; 2004 Aug 15; 21(8):931-5. PubMed ID: 15270801
    [Abstract] [Full Text] [Related]

  • 14. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H, Guo L.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Aug 15; 22(1):56-8. PubMed ID: 9868029
    [Abstract] [Full Text] [Related]

  • 15. [Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy].
    Parlapiano C, Paoletti V, Campana E, Rota C, Donnarumma L, Musca A, Andreani D.
    Minerva Med; 1995 Mar 15; 86(3):105-20. PubMed ID: 7603606
    [No Abstract] [Full Text] [Related]

  • 16. [Studies on diabetic retinopathy. 3. Fibrinolytic activity].
    Ogawa Y.
    Nippon Ganka Gakkai Zasshi; 1967 Sep 15; 71(9):1647-54. PubMed ID: 5626457
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical study of proliferative diabetic retinopathy (author's transl)].
    Fukuda M, Tamura T, Abe T, Kasahara T.
    Nippon Ganka Gakkai Zasshi; 1976 Nov 10; 80(11):1514-25. PubMed ID: 1034429
    [No Abstract] [Full Text] [Related]

  • 18. [Diabetic retinopathy in newly diagnosed patients with type II diabetes mellitus].
    Tălu S, Kaucsar E, Soreanu A.
    Oftalmologia; 2002 Nov 10; 54(3):27-30. PubMed ID: 12723193
    [Abstract] [Full Text] [Related]

  • 19. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.
    Wien Klin Wochenschr; 2005 Oct 10; 117(19-20):707-10. PubMed ID: 16416371
    [Abstract] [Full Text] [Related]

  • 20. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr 10; 20(2):131-4. PubMed ID: 12673582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.